This definition appears very rarely
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other meanings of HAC
We have 290 other definitions for HAC
in our Acronym Attic
Samples in periodicals archive:
Topics include: hypoadrenocorticism in dogs and other species, primary functioning adrenal tumors producing signs similar to hyperadrenocorticism including atypical syndromes in cats, diabetes mellitus in dogs and other species, insulinoma, hypothyroidism, hyposomatotropism, acromegaly, estrogen- and androgen-related disorders, and adrenal dysfunction and sex hormones.
The group said in a trading update it had launched several new products across the European Union and its Vetoryl product - a treatment for canine hyperadrenocorticism - received approval in the United States, Australia and Canada.
Additionally, VETORYL has received designation status as a Minor Use Drug for treatment of hyperadrenocorticism caused by adrenal tumors -- the first drug to receive an approval for this indication and the first drug to receive a Minor Use designation in dogs.
If a dog has Cushing's disease, or hyperadrenocorticism, these glands produce excessive amounts of the hormone.
Hyperadrenocorticism, attenuated inflammation, and the life-prolonging action of food restriction in mice.
Nasdaq: DAHI; Toronto: DAH) announced today that it has launched a pivotal (Phase III equivalent) clinical trial evaluating the use of Anipryl(R) (selegiline hydrochloride) for the treatment of canine Cushing's disease (also known as Pituitary Dependent Hyperadrenocorticism or "PDH") to satisfy the pre-marketing regulatory approval requirements of the U.
NYSE:PFE), has been cleared by the Brazilian Ministerio da Agricultura e de Abastecimento for the treatment of uncomplicated pituitary-dependent hyperadrenocorticism (PDH or Cushing's disease) and age associated cognitive dysfunction (CDS) in dogs.
Mr Page said a high point of last year was the approval of Vetoryl, a treatment for canine hyperadrenocorticism, by the US Food and Drug Administration.